bpc-157 cuprizone demyelination Frontiers Multisensory gamma stimulation mitigates the

Where they overlap and where they don't Complementary Mechanism Targets Target Origin BPC-157 Gastric juice protein fragment (15 amino acids) TB-500 Thymosin Beta-4 fragment (LKKTETQ region) Target Primary action BPC-157 Local tissue repair signaling TB-500 Systemic cell migration and mobilization Target Angiogenesis BPC-157 VEGF upregulation, NO pathway TB-500 Endothelial migration, VEGF crosstalk Target Cell migration BPC-157 Indirect, via growth factors TB-500 Direct (G-actin sequestering) Target Best-evidence tissue BPC-157 Tendon, gut, gastric mucosa (preclinical) TB-500 Cardiac, corneal, skin (preclinical + early human T4) Target Reported in vivo half-life BPC-157 ~4 hours (animal estimates) TB-500 ~23 days (animal estimates) Half-life figures are pharmacokinetic estimates from animal studies

Most vials dissolve within 2-5 minutes of gentle rolling

Fang Wang, BS1

Receive Your Medication in 5-7 Business Days (If approved) Note: If you are not eligible for MIC UltraBurn for ANY reason, we will issue a full refund of your purchase price immediately

One of the most common concerns about peptide therapy is the idea of administering injections at home